Muralidhar Bali Insider Profile
4 Followers
Muralidhar Bali, Director at Spruce Biosciences, holds 8.45M shares in Exicure (Ticker: XCUR), holds 2.07M shares in OnKure Therapeutics (Ticker: OKUR), holds 1.79M shares in Spruce Biosciences (Ticker: SPRB). Most recently, Muralidhar Bali Bought ― shares of Exicure on May 19, 2022 for an estimated value of $279.70K.
Muralidhar Bali's Trading History
You May Also Like
Muralidhar Bali insider profile FAQ
What is the percentage of profitable transactions made by Muralidhar Bali?
The percentage of profitable transactions made by Muralidhar Bali is 0%.
What is the average return per transaction made by Muralidhar Bali?
The average return per transaction made by Muralidhar Bali is -71.10%.
What stocks does Muralidhar Bali hold?
Muralidhar Bali holds: SPRB, XCUR, OKUR stocks.
What was Muralidhar Bali’s latest transaction?
Muralidhar Bali’s latest transaction was an Informative Buy of $279.70K.
What was Muralidhar Bali's most profitable transaction?
Muralidhar Bali’s most profitable transaction was an Informative Buy of XCUR stock on December 23, 2019. The return on the trade was -28.20%.
What is Muralidhar Bali's role in Spruce Biosciences?
Muralidhar Bali's role in Spruce Biosciences is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
